HemOnc Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents

Fellows receive awards for minority health, health disparities research

Chemoradiation researcher receives ASTRO honorary membership

Fox Chase Cancer Center appoints head of medical oncology

Association of Community Cancer Centers names award recipients

American Cancer Society, public health groups call for R rating on films that portray smoking

Roswell Park Cancer Institute dosimetrist to lead national association

AACR: Breakthroughs in cancer research require ‘strong federal commitment’

USPSTF: Cervical cancer screening ‘critically important’ in saving women’s lives

Cover Story

Obesity, hepatitis C epidemics drive ‘alarming’ increase in liver cancer incidence, mortality

Editorial

Physical activity and cancer outcomes: Growing evidence for the oncologist

John Sweetenham, MD

FDA News

FDA grants breakthrough therapy designation to Imfinzi for non-small cell lung cancer

FDA approves Opdivo for subtype of metastatic colorectal cancer

FDA grants orphan drug designation to H3B-8800 for leukemia

FDA grants priority review to Gazyva for previously untreated follicular lymphoma

In the Journals Plus

Vitamin A supplementation may improve outcomes after pediatric bone marrow transplant

Risk for secondary cancers after Kaposi sarcoma has declined

Malaria drug improves efficacy of glioblastoma treatment

Ferrous sulfate effective for pediatric iron-deficiency anemia

Overweight, obese adolescents at greater risk for colorectal cancer

Older patients with cancer may burden caregivers by overestimating physical abilities

Germline mutations found in sporadic pancreatic cancer

Half of women with early-stage breast cancer consider prophylactic double mastectomy

Early palliative care may improve quality of life in patients with lung, gastrointestinal cancers

Anal cancer survivors have increased risk for HPV–related second cancers

Afatinib improves progression-free survival in subtypes of head and neck squamous cell carcinoma

ASCO updates guideline on systemic therapy for non-small cell lung cancer

Aggressive breast cancers in black women may explain survival disparities

Autologous stem cell transplant fails to improve outcomes in double-hit lymphoma

CAR T-cell therapy effective for chronic lymphocytic leukemia

Meeting News

Abiraterone acetate plus prednisone improves health-related quality of life in metastatic prostate cancer

Nivolumab superior to ipilimumab for adjuvant treatment of surgically resected melanoma

Pembrolizumab extends survival in urothelial cancer

Addition of ramucirumab to docetaxel extends PFS in advanced urothelial cancer

Nivolumab with, without ipilimumab benefits patients with malignant pleural mesothelioma

Concomitant chemoradiation should be standard for locally advanced cervical cancer

Convection-enhanced delivery appears safe in pediatric diffuse intrinsic pontine glioma

Hybrid minimally invasive esophagectomy reduces morbidity in esophageal cancer

Point/Counter

Should patients with unresectable HCC undergo systemic therapy?

Advertisement
Advertisement